Citadel Advisors - Tenax Therapeutics ownership

Tenax Therapeutics's ticker is and the CUSIP is 88032L506. A total of 17 filers reported holding Tenax Therapeutics in Q3 2023. The put-call ratio across all filers is - and the average weighting 0.0%.

Quarter-by-quarter ownership
Citadel Advisors ownership history of Tenax Therapeutics
ValueSharesWeighting
Q3 2023$4,43215,0330.00%
Other shareholders
Tenax Therapeutics shareholders Q3 2023
NameSharesValueWeighting ↓
Virtu Financial LLC 84,361$390.00%
TUCKER ASSET MANAGEMENT LLC 2$10.00%
Corient Private Wealth LLC 191,460$89,0290.00%
Avantax Planning Partners, Inc. 10,002$4,6510.00%
Allworth Financial LP 1$10.00%
Horan Securities, Inc. 1$00.00%
WELLS FARGO & COMPANY/MN 65$300.00%
STATE STREET CORP 95,122$44,2320.00%
MORGAN STANLEY 680$3160.00%
BlackRock Inc. 23,922$11,1240.00%
View complete list of Tenax Therapeutics shareholders